Dickinson and Company) Archives - CDR

BD acquires GSL Solutions

March 4, 2021 by Chain Drug Review BD (Becton, Dickinson and Company), GSL Solutions (GSL), Mike Garrison Leading Headlines, Pharmacy, Supplier News

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) has acquired GSL Solutions (GSL), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including

BD, BioGX announce FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.

March 20, 2020 by Chain Drug Review BD (Becton, BD MAX Molecular Diagnostic Platform, BioGX, COVID-19, Dickinson and Company) Pharmacy, Supplier News

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) a leading global medical technology company, and BioGX, a molecular diagnostics company, announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and Drug Administration (FDA) for new diagnostic tests that, if authorized, would increase the potential capacity to screen for COVID-19 (coronavirus)